Article
Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?
Scandinavian journal of rheumatology - 1 May 2026
Özomay Baykal G, Türkmen Ş, Atamyıldız Uçar S, Tunce E, Kara Çanlıoğlu N, Sözeri B
Abstract excerpt
OBJECTIVE: To examine the demographic and clinical features of paediatric familial Mediterranean fever (FMF) patients with a heterozygous Mediterranean fever (MEFV) gene mutation, focusing on colchicine discontinuation and factors linked to sustained remission. METHOD: This retrospective study included 2325 paediatric FMF patients followed at a tertiary rheumatology clinic between August 2016 and February 2024....
Topics
Join the communities discussing this publication.
